Your browser doesn't support javascript.
loading
[Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
Nishi, T; Funasako, M; Hata, N; Andoh, K; Itoh, Y; Ono, H; Itoh, K; Sato, Y; Sato, H; Taniji, M; Nakai, S; Ueda, A; Fujimoto, H; Ohata, M.
Affiliation
  • Nishi T; Dept. of Internal Medicine, Wakayama Medical College Kihoku Hospital.
Gan To Kagaku Ryoho ; 23(10): 1331-4, 1996 Sep.
Article in Ja | MEDLINE | ID: mdl-8831748
ABSTRACT
Five cases of myelodysplastic syndrome were treated with cytarabine ocfosfate. Ocfosfate (100-200 mg) was orally administered for 14 days with 14 days' interval. Etoposide was combined in one case, and nartograstim was added in two cases. Two of the five cases achieved remission, one case having complete remission, and another case showing a good response. Their remission durations were 141 and 112 days, respectively. Further improvement of therapy is needed to achieve a higher remission rate and a longer remission duration.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Arabinonucleotides / Myelodysplastic Syndromes / Cytidine Monophosphate / Antineoplastic Agents Limits: Female / Humans / Male / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 1996 Type: Article
Search on Google
Database: MEDLINE Main subject: Arabinonucleotides / Myelodysplastic Syndromes / Cytidine Monophosphate / Antineoplastic Agents Limits: Female / Humans / Male / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 1996 Type: Article